OrbiMed Capital GP V LLC
- SEC CIK
- 0001615374
In the past year, 1 open-market purchase filing worth $5.00M and 2 sale filings worth $2.19M.
Current role at each company
- ACET Adicet Bio, Inc.10% Owneras of Apr 9, 2026
- PMVP PMV Pharmaceuticals, Inc.10% Owneras of Oct 27, 2025
- CRVS Corvus Pharmaceuticals, Inc.Director, 10% Owneras of Jul 1, 2025
- TCDA Tricida, Inc.Director, 10% Owneras of Nov 25, 2022
- CMPX Compass Therapeutics, Inc.Director, 10% Owneras of Nov 10, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $5.00M
- 1 filing
- Sold
- $2.19M
- 2 filings
- Net
- +$2.81M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists OrbiMed Capital GP V LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ACET Adicet Bio, Inc.
10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 9, 2026 (view filing)5:38 PM ET | Apr 7-8 | 2 days | OrbiMed Advisors LLC and 7 others10% Owner | SSale | −104.7K | $6.45 | −$674.8K | −100.0%0 after | 4 lots |
| Oct 10, 2025 (view filing)8:06 PM ET | Oct 8 | 2 days | OrbiMed Advisors LLC and 7 others10% Owner | PPurchase | +5.00M | $1.00 | +$5.00M | New position4.49M after | 2 lots |
| Jan 26, 2024 (view filing)7:14 PM ET | Jan 25 | 1 day | OrbiMed Advisors LLC and 7 othersDirector, 10% Owner | PPurchase | +3.13M | $2.40 | +$7.50M | New position1.26M after | 3 lotsDuplicate filing |
| Jun 29, 2023 (view filing)4:46 PM ET | Jun 27 | 2 days | OrbiMed Advisors LLC and 8 othersDirector, 10% Owner | PPurchase | +875.0K | $2.09 | +$1.83M | New position748.1K after | 4 lotsDuplicate filing |
PMVP PMV Pharmaceuticals, Inc.
10% Owner5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 2025 (view filing)5:19 PM ET | Oct 23 | 4 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −1.00M | $1.52 | −$1.52M | −16.7%4.98M after | |
| Sep 12, 2025 (view filing)5:09 PM ET | Sep 10 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −500.0K | $1.80 | −$900.0K | −7.7%5.98M after | |
| Nov 24, 2023 (view filing)4:38 PM ET | Nov 22 | 2 days | OrbiMed Advisors LLC and 2 others10% Owner | SSale | −87.8K | $2.23 | −$195.8K | −100.0%0 after | |
| May 31, 2022 (view filing)4:36 PM ET | May 26 | 5 days | OrbiMed Advisors LLC and 2 others10% Owner | SSale | −26.3K | $15.93 | −$418.2K | −23.0%87.8K after | |
| Mar 31, 2022 (view filing)5:30 PM ET | Mar 29-31 | 2 days | OrbiMed Advisors LLC and 3 others10% Owner | SSale | −474.5K | $21.63 | −$10.3M | −100.0%0 after | 3 lots |
CRVS Corvus Pharmaceuticals, Inc.
Director, 10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2025 (view filing)9:23 PM ET | Jun 27 | 4 days | OrbiMed Advisors LLC and 1 otherDirector, 10% Owner | SSale | −1.18M | $4.16 | −$4.89M | −14.1%7.17M after | |
| May 8, 2024 (view filing)8:28 PM ET | May 6 | 2 days | OrbiMed Advisors LLC and 1 otherDirector, 10% Owner | PPurchase | +2.84M | $1.73 | +$2.50M | –1.40M after | Derivative2 lots |
| Sep 22, 2021 (view filing)5:27 PM ET | Sep 20 | 2 days | OrbiMed Advisors LLC and 1 otherDirector, 10% Owner | SSaleCommon Stock, $0.0001 par value | −1.11M | $6.09 | −$6.76M | −13.8%6.94M after | Duplicate filing |
TCDA Tricida, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2022 (view filing)8:13 PM ET | Nov 22-25 | 3 days | OrbiMed Advisors LLC and 1 otherDirector, 10% Owner | SSale | −10.3M | $0.2145 | −$2.21M | −100.0%0 after | 3 lotsDuplicate filing |
CMPX Compass Therapeutics, Inc.
Director, 10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2022 (view filing)4:44 PM ET | Nov 8 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +402.0K | $3.21 | +$1.29M | +2.7%15.2M after | Duplicate filing |
| May 13, 2022 (view filing)5:45 PM ET | May 11-13 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +192.5K | $2.18 | +$420.5K | +1.3%14.8M after | 3 lotsDuplicate filing |
| May 10, 2022 (view filing)6:21 PM ET | May 6-10 | 4 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +125.4K | $1.57 | +$197.3K | +0.9%14.6M after | 3 lotsDuplicate filing |
| Nov 8, 2021 (view filing)9:06 PM ET | Nov 4 | 4 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +5.36M | $3.50 | +$18.8M | New position3.57M after | 2 lotsDuplicate filing |